Final overall survival (OS) results from the INAVO120 trial (NCT04191499) confirmed that the addition of inavolisib (Itovebi) ...

Diabetes is a leading global health and economic challenge, affecting over 800 million people worldwide, with over 80% ...

Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers federal public health agencies. There were 26.4 deaths per 100,000 people from diabetes ...

The incidence of type 2 diabetes mellitus is increasing among youths. Once-weekly treatment with dulaglutide, a glucagon-like peptide-1 receptor ... thyroid C-cell hyperplasia, or medullary ...

Now, a study of 170,000 patient records suggests there's a slightly lower risk of obesity-related cancers in U.S. adults with diabetes who took these popular medications compared to those who took ...

Autoantibodies positivity was associated with a shorter time to diabetes development among children with acute and chronic pancreatitis.

The use of finerenone in patients with type 2 diabetes and a wider range of ... and all authors had access to and participated in the interpretation of the analyzed data. The first and second ...

Orforglipron significantly reduced HbA1c levels by 1.3% (3mg), 1.6% (12mg), and 1.5% (36mg) compared with 0.1% in the placebo arm. Orforglipron, a once-daily glucagon-like peptide-1 (GLP-1 ...